American Portfolios Advisors Biogen Inc. Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Biogen Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 8,744 shares of BIIB stock, worth $2.03 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

8,744

Holding current value

$2.03 Million

% of portfolio

0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$194.69 - $268.46 $1.7 Million - $2.35 Million	8,744 New	8,744 $2.33 Billion
Q2 2022 Mar 20, 2023	BUY	$187.54 - $223.02 $471,288 - $560,449	2,513 Added 28.74%	11,257 $2.3 Billion
Q1 2022 Mar 21, 2023	BUY	$193.77 - $244.14 $495,469 - $624,265	2,557 Added 29.24%	11,301 $2.38 Billion
Q4 2021 Mar 21, 2023	BUY	$223.92 - $287.77 $537,408 - $690,648	2,400 Added 27.45%	11,144 $2.67 Billion
Q3 2021 Mar 22, 2023	BUY	$282.99 - $369.05 $672,101 - $876,493	2,375 Added 27.16%	11,119 $3.15 Billion

Q2 2021 Mar 22, 2023	BUY	$259.0 - $414.71 $415,954 - $666,024	1,606 Added 18.37%	10,350 $3.58 Billion
Q1 2021 Mar 22, 2023	BUY	$242.95 - $284.63 $389,448 - $456,261	1,603 Added 18.33%	10,347 $2.89 Billion
Q4 2020 Mar 22, 2023	BUY	$236.26 - $355.63 $373,999 - $562,962	1,583 Added 18.1%	10,327 $2.53 Billion
Q3 2020 Mar 22, 2023	BUY	$264.77 - $305.71 $420,454 - $485,467	1,588 Added 18.16%	10,332 $2.93 Billion
Q2 2020 Mar 24, 2023	SELL	$258.66 - $342.55 $194,253 - $257,255	-751 Reduced 6.74%	10,384 $2.78 Billion
Q1 2020 Mar 24, 2023	BUY	$268.85 - $341.04 $642,820 - $815,426	2,391 Added 27.34%	11,135 $3.52 Billion
Q4 2019 Mar 24, 2023	BUY	$220.06 - $304.07 $599,003 - $827,678	2,722 Added 31.13%	11,466 $3.4 Billion
Q3 2019 Mar 24, 2023	BUY	$217.44 - $243.88 $75,234 - $84,382	346 Added 2.98%	11,939 $2.78 Billion
Q2 2019 Mar 24, 2023	BUY	$219.29 - $241.72 $624,757 - $688,660	2,849 Added 32.58%	11,593 $2.71 Billion
Q1 2019 Mar 24, 2023	BUY	$216.71 - $338.96 $34,023 - $53,216	157 Added 10.8%	1,611 $381 Million
Q4 2018 Mar 24, 2023	BUY	$278.5 - $352.75 $8,355 - $10,582	30 Added 2.11%	1,454 $438 Million
Q3 2018 Mar 24, 2023	SELL	$293.51 - $383.83 $2.15 Million - $2.81 Million	-7,320 Reduced 83.71%	1,424 $503 Million
Q2 2018 Mar 24, 2023	SELL	$257.52 - $306.91 $4,892 - $5,831	-19 Reduced 1.35%	1,386 $402 Million
Q1 2018 Mar 24, 2023	SELL	$260.13 - $367.91 $1.91 Million - $2.7 Million	-7,339 Reduced 83.93%	1,405 $385 Million
Q4 2017 Mar 24, 2023	SELL	$307.64 - $344.58 $2.31 Million - $2.59 Million	-7,520	1,224 $390 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Biogen Inc. Transaction History